Transforming nanomedicine manufacturing toward Quality by Design and microfluidics.

[1]  H. Santos,et al.  The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems , 2018, Expert opinion on drug delivery.

[2]  A. Bohr,et al.  Inhalable siRNA‐loaded nano‐embedded microparticles engineered using microfluidics and spray drying , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  A. Elaissari,et al.  Nanoprecipitation process: From encapsulation to drug delivery. , 2017, International journal of pharmaceutics.

[4]  Bingsheng Wang,et al.  A review on self-assembly in microfluidic devices , 2017 .

[5]  Hongbo Zhang,et al.  Current developments and applications of microfluidic technology toward clinical translation of nanomedicines☆ , 2017, Advanced drug delivery reviews.

[6]  Robert Langer,et al.  Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures , 2017, Expert opinion on drug delivery.

[7]  J. Wulff,et al.  Controlling Structure and Function of Polymeric Drug Delivery Nanoparticles Using Microfluidics. , 2017, Molecular pharmaceutics.

[8]  Warren C. W. Chan,et al.  Nanomedicine 2.0. , 2017, Accounts of chemical research.

[9]  Jukka Rantanen,et al.  High-Throughput Fabrication of Nanocomplexes Using 3D-Printed Micromixers. , 2017, Journal of pharmaceutical sciences.

[10]  Richard M Maceiczyk,et al.  Small but Perfectly Formed? Successes, Challenges, and Opportunities for Microfluidics in the Chemical and Biological Sciences , 2017 .

[11]  Elicia Maine,et al.  Raising financing through strategic timing. , 2017, Nature nanotechnology.

[12]  Zuanguang Chen,et al.  Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy , 2017, Front. Pharmacol..

[13]  Jarno Salonen,et al.  Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation. , 2017, Nano letters.

[14]  Yanhui Zhao,et al.  Microfluidic Hydrodynamic Focusing for Synthesis of Nanomaterials. , 2016, Nano today.

[15]  Talia Flanagan,et al.  Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid. , 2016, Journal of pharmaceutical sciences.

[16]  Anurag S Rathore,et al.  Role of Knowledge Management in Development and Lifecycle Management of Biopharmaceuticals , 2016, Pharmaceutical Research.

[17]  D. Needham,et al.  Bottom up design of nanoparticles for anti-cancer diapeutics: “put the drug in the cancer’s food” , 2016, Journal of drug targeting.

[18]  Lili He,et al.  Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells , 2016, Front. Pharmacol..

[19]  Jim Nolan,et al.  A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products , 2016, The AAPS Journal.

[20]  Fabian Kiessling,et al.  Cancer nanomedicine: Is targeting our target? , 2016, Nature reviews. Materials.

[21]  D. Neuman,et al.  Patent Watch: Nanomedicine patents highlight importance of production methods , 2016, Nature Reviews Drug Discovery.

[22]  Kristofer J. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[23]  R. Coleman,et al.  Equivalency challenge: Evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model. , 2016, Gynecologic oncology.

[24]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[25]  E. Alphandéry,et al.  Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects , 2015, Expert review of anticancer therapy.

[26]  J. Rantanen,et al.  The Future of Pharmaceutical Manufacturing Sciences , 2015, Journal of pharmaceutical sciences.

[27]  R. Bosetti.  Cost-effectiveness of nanomedicine: the path to a future successful and dominant market? , 2015, Nanomedicine.

[28]  P. Couvreur,et al.  Solvent selection causes remarkable shifts of the "Ouzo region" for poly(lactide-co-glycolide) nanoparticles prepared by nanoprecipitation. , 2015, Nanoscale.

[29]  Piotr Grodzinski,et al.  NCI investment in nanotechnology: achievements and challenges for the future. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[30]  L. Lévy,et al.  Delivering nanomedicines to patients: a practical guide. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[31]  Hélder A. Santos,et al.  A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties , 2015, Advanced materials.

[32]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Agnes G Oomen,et al.  Horizon scan of nanomedicinal products. , 2015, Nanomedicine.

[34]  V. Weissig,et al.  Nanopharmaceuticals (part 2): products in the pipeline , 2015, International journal of nanomedicine.

[35]  Davoud Jafari,et al.  Mixing enhancement in a passive micromixer with convergent–divergent sinusoidal microchannels and different ratio of amplitude to wave length , 2014 .

[36]  Benjamin C. Tang,et al.  Managing diabetes with nanomedicine: challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[37]  Anette Müllertz,et al.  The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. , 2014, Journal of pharmaceutical sciences.

[38]  Tracy K. Pettinger,et al.  Nanopharmaceuticals (part 1): products on the market , 2014, International journal of nanomedicine.

[39]  Martin G Pomper,et al.  State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[40]  R. Babu,et al.  Nanomedicine Scale-up Technologies: Feasibilities and Challenges , 2014, AAPS PharmSciTech.

[41]  Ping-Chang Lin,et al.  Techniques for physicochemical characterization of nanomaterials. , 2014, Biotechnology advances.

[42]  A. Yetisen,et al.  Commercialization of microfluidic devices. , 2014, Trends in biotechnology.

[43]  Ali K Yetisen,et al.  Patent protection and licensing in microfluidics. , 2014, Lab on a chip.

[44]  James M. Utterback,et al.  Radical Innovation from the Confluence of Technologies: Innovation Management Strategies for the Emerging Nanobiotechnology Industry , 2014 .

[45]  G. K. Raju,et al.  Understanding Pharmaceutical Quality by Design , 2014, The AAPS Journal.

[46]  Robert Langer,et al.  Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer , 2014, ACS nano.

[47]  J. Lovrić,et al.  Nanotherapeutics in the EU: an overview on current state and future directions , 2014, International journal of nanomedicine.

[48]  Sosaku Ichikawa,et al.  Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery. , 2013, Advanced drug delivery reviews.

[49]  Kinam Park,et al.  Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.

[50]  D. Crommelin,et al.  Towards more effective advanced drug delivery systems. , 2013, International journal of pharmaceutics.

[51]  M. Malmsten,et al.  Carbon Dioxide-Mediated Generation of Hybrid Nanoparticles for Improved Bioavailability of Protein Kinase Inhibitors , 2013, Pharmaceutical Research.

[52]  D. Thompson,et al.  Microfluidic Assembly of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantane Host:Guest pDNA Nanoparticles. , 2013, Biomaterials science.

[53]  V. Samper,et al.  Microfluidics: A Groundbreaking Technology for PET Tracer Production? , 2013, Molecules.

[54]  Xingyu Jiang,et al.  A microfluidic origami chip for synthesis of functionalized polymeric nanoparticles. , 2013, Nanoscale.

[55]  A. Woolley,et al.  Advances in microfluidic materials, functions, integration, and applications. , 2013, Chemical reviews.

[56]  Christian Holtze,et al.  Large-scale droplet production in microfluidic devices—an industrial perspective , 2013 .

[57]  M. Buchsbaum,et al.  Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer. , 2013, Lab on a chip.

[58]  A. Ganem-Rondero,et al.  Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles. , 2012, Recent patents on drug delivery & formulation.

[59]  Buket Aksu,et al.  Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT). , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[60]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Robert Langer,et al.  Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. , 2012, Nano letters.

[62]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[63]  Neil Desai,et al.  Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[64]  A. Tocchio,et al.  Nanotechnology in Medicine: From Inception to Market Domination , 2012, Journal of drug delivery.

[65]  Wenbin Lin,et al.  Are high drug loading nanoparticles the next step forward for chemotherapy? , 2012, Nanomedicine.

[66]  J. Scannell,et al.  Diagnosing the decline in pharmaceutical R&D efficiency , 2012, Nature Reviews Drug Discovery.

[67]  A S Rathore,et al.  Use of computational fluid dynamics as a tool for establishing process design space for mixing in a bioreactor , 2012, Biotechnology progress.

[68]  H. Fessi,et al.  Preparation of vitamin E loaded nanocapsules by the nanoprecipitation method: from laboratory scale to large scale using a membrane contactor. , 2012, International journal of pharmaceutics.

[69]  Philip Chi Lip Kwok,et al.  Production methods for nanodrug particles using the bottom-up approach. , 2011, Advanced drug delivery reviews.

[70]  A. Elaissari,et al.  Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison. , 2011, Advances in colloid and interface science.

[71]  Lawrence X. Yu,et al.  In vitro and in vivo characterizations of PEGylated liposomal doxorubicin. , 2011, Bioanalysis.

[72]  Johannes G Khinast,et al.  An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[73]  Ranjita Shegokar,et al.  Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.

[74]  Feng Guo,et al.  A rapid pathway toward a superb gene delivery system: programming structural and functional diversity into a supramolecular nanoparticle library. , 2010, ACS nano.

[75]  C. Lok.  Nanotechnology: Small wonders , 2010, Nature.

[76]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications , 2010, Biotechnology and bioengineering.

[77]  Pedro Hernandez-Abad,et al.  Quality by design case study: an integrated multivariate approach to drug product and process development. , 2009, International journal of pharmaceutics.

[78]  Nathan Blow,et al.  Microfluidics: the great divide , 2009, Nature Methods.

[79]  Rainer H Müller,et al.  Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.

[80]  Lawrence X. Yu.  Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.

[81]  Volker Wagner,et al.  The emerging nanomedicine landscape , 2006, Nature Biotechnology.

[82]  Bruno C. Hancock,et al.  Process simulation in the pharmaceutical industry: a review of some basic physical models. , 2006, Journal of pharmaceutical sciences.

[83]  D. Beebe,et al.  Controlled microfluidic interfaces , 2005, Nature.

[84]  Dong Sung Kim,et al.  A serpentine laminating micromixer combining splitting/recombination and advection. , 2005, Lab on a chip.

[85]  H. Fessi,et al.  Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods , 2004, Pharmaceutical Research.

[86]  Michael C. L. Ward,et al.  Investigation of mixing in a cross-shaped micromixer with static mixing elements for reaction kinetics studies , 2003 .

[87]  P. Couvreur,et al.  The Design of Nanoparticles Obtained by Solvent Evaporation: A Comprehensive Study , 2003 .

[88]  R. Mischler,et al.  Inflexal V a trivalent virosome subunit influenza vaccine: production. , 2002, Vaccine.

[89]  I. Mezić,et al.  Chaotic Mixer for Microchannels , 2002, Science.

[90]  R. Gurny,et al.  Aqueous nanodispersions prepared by a salting-out process , 1992 .

[91]  Sarwar Beg,et al.  Nanotechnology-based drug products , 2018 .

[92]  Wei Li,et al.  A Nano‐in‐Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals , 2017 .

[93]  Andreas Dietzel,et al.  Microsystems for Pharmatechnology , 2016 .

[94]  Jun Wang,et al.  Nanomedicine-mediated cancer stem cell therapy. , 2016, Biomaterials.

[95]  Elicia Maine,et al.  The emergence of the nanobiotechnology industry. , 2014, Nature nanotechnology.

[96]  J. Rantanen,et al.  Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach. , 2014, Current pharmaceutical design.

[97]  A. Bohr,et al.  Preparation of nanoscale pulmonary drug delivery formulations by spray drying. , 2014, Advances in experimental medicine and biology.

[98]  V. Venditto,et al.  Cancer nanomedicines: so many papers and so few drugs! , 2013, Advanced drug delivery reviews.

[99]  K. Jain.  Research and Future of Nanomedicine , 2012 .

[100]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[101]  Wagner Volker,et al.  Nanomedicine: Drivers for development and possible impacts , 2008 .

[102]  Nam-Trung Nguyen,et al.  Micromixers: Fundamentals, Design, and Fabrication , 2008 .

[103]  M. Bally,et al.  The liposomal formulation of doxorubicin. , 2005, Methods in enzymology.

[104]  J. Adler-Moore,et al.  AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. , 2002, The Journal of antimicrobial chemotherapy.

[105]  D. Quintanar-Guerrero,et al.  Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. , 1998, Drug development and industrial pharmacy.

[106]  R. Gurny,et al.  New approach for the preparation of nanoparticles by an emulsification-diffusion method , 1995 .

[107]  J. Adler-Moore,et al.  AmBisome targeting to fungal infections. , 1994, Bone marrow transplantation.

[108]  J. Adler-Moore,et al.  Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin B , 1993 .

[109]  N. Peppas,et al.  Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs , 1981 .